Source link : https://www.newshealth.biz/health-news/novel-drug-shows-a-signal-to-improve-nhcm/
ATLANTA — A investigative drug that uses a novel pathway to target cardiac metabolism was safe and well-tolerated and showed a signal to improve cardiac function in symptomatic patients with moderate nonobstructive hypertrophic cardiomyopathy (nHCM) in a phase 2 proof-of-concept trial. The IMPROVE-HCM trial randomized 67 nHCM patients to the drug ninerafaxstat or placebo. Ninerafaxstat […]
Author : News Health
Publish date : 2024-04-12 13:06:53
Copyright for syndicated content belongs to the linked Source.